Supplementary Figure S1 from Hyperthermic Intrathoracic Chemotherapy Modulates the Immune Microenvironment of Pleural Mesothelioma and Improves the Impact of Dual Immune Checkpoint Inhibition Article Swipe
Yameng Hao
,
Aspasia Gkasti
,
Amy J. Managh
,
Julien Dagher
,
Alexandros Sifis
,
Luca Tiron
,
Louis-Emmanuel Chriqui
,
Damien N. Marie
,
Olga De Souza Silva
,
Michel Christodoulou
,
Solange Peters
,
Johanna A. Joyce
,
Thorsten Krueger
,
Michel González
,
Etienne Abdelnour‐Berchtold
,
Christine Sempoux
,
Daniel Clerc
,
Hugo Teixeira Farinha
,
Martin Hübner
,
Etienne Meylan
,
Paul J. Dyson
,
Sabrina Cavin
,
Jean Yannis Perentes
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.28333082
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.28333082
Supplementary Figure S1: Evaluation of the impact of heat adjunct on cisplatin cytotoxicity.
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/2326-6066.28333082
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4407109620
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4407109620Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/2326-6066.28333082Digital Object Identifier
- Title
-
Supplementary Figure S1 from Hyperthermic Intrathoracic Chemotherapy Modulates the Immune Microenvironment of Pleural Mesothelioma and Improves the Impact of Dual Immune Checkpoint InhibitionWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-02-03Full publication date if available
- Authors
-
Yameng Hao, Aspasia Gkasti, Amy J. Managh, Julien Dagher, Alexandros Sifis, Luca Tiron, Louis-Emmanuel Chriqui, Damien N. Marie, Olga De Souza Silva, Michel Christodoulou, Solange Peters, Johanna A. Joyce, Thorsten Krueger, Michel González, Etienne Abdelnour‐Berchtold, Christine Sempoux, Daniel Clerc, Hugo Teixeira Farinha, Martin Hübner, Etienne Meylan, Paul J. Dyson, Sabrina Cavin, Jean Yannis PerentesList of authors in order
- Landing page
-
https://doi.org/10.1158/2326-6066.28333082Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/2326-6066.28333082Direct OA link when available
- Concepts
-
Cisplatin, Mesothelioma, Immune system, Medicine, Tumor microenvironment, Chemotherapy, Cancer research, Immune checkpoint, Cytotoxicity, Dual (grammatical number), Oncology, Immunotherapy, Internal medicine, Immunology, Biology, Pathology, In vitro, Literature, Art, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4407109620 |
|---|---|
| doi | https://doi.org/10.1158/2326-6066.28333082 |
| ids.doi | https://doi.org/10.1158/2326-6066.28333082 |
| ids.openalex | https://openalex.org/W4407109620 |
| fwci | 0.0 |
| type | preprint |
| title | Supplementary Figure S1 from Hyperthermic Intrathoracic Chemotherapy Modulates the Immune Microenvironment of Pleural Mesothelioma and Improves the Impact of Dual Immune Checkpoint Inhibition |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11026 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9782000184059143 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Occupational and environmental lung diseases |
| topics[1].id | https://openalex.org/T11356 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9621000289916992 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Pleural and Pulmonary Diseases |
| topics[2].id | https://openalex.org/T12996 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9492999911308289 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1305 |
| topics[2].subfield.display_name | Biotechnology |
| topics[2].display_name | Cancer Research and Treatments |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778239845 |
| concepts[0].level | 3 |
| concepts[0].score | 0.817870557308197 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q412415 |
| concepts[0].display_name | Cisplatin |
| concepts[1].id | https://openalex.org/C2777407522 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7890313863754272 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1077603 |
| concepts[1].display_name | Mesothelioma |
| concepts[2].id | https://openalex.org/C8891405 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5757443308830261 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[2].display_name | Immune system |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.5644565224647522 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C2776107976 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5321850776672363 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1786433 |
| concepts[4].display_name | Tumor microenvironment |
| concepts[5].id | https://openalex.org/C2776694085 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5094864964485168 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[5].display_name | Chemotherapy |
| concepts[6].id | https://openalex.org/C502942594 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4733445942401886 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[6].display_name | Cancer research |
| concepts[7].id | https://openalex.org/C2780851360 |
| concepts[7].level | 4 |
| concepts[7].score | 0.47064799070358276 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q21686041 |
| concepts[7].display_name | Immune checkpoint |
| concepts[8].id | https://openalex.org/C109316439 |
| concepts[8].level | 3 |
| concepts[8].score | 0.46917206048965454 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q246181 |
| concepts[8].display_name | Cytotoxicity |
| concepts[9].id | https://openalex.org/C2780980858 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4238210618495941 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q110022 |
| concepts[9].display_name | Dual (grammatical number) |
| concepts[10].id | https://openalex.org/C143998085 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3917440176010132 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[10].display_name | Oncology |
| concepts[11].id | https://openalex.org/C2777701055 |
| concepts[11].level | 3 |
| concepts[11].score | 0.32911813259124756 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[11].display_name | Immunotherapy |
| concepts[12].id | https://openalex.org/C126322002 |
| concepts[12].level | 1 |
| concepts[12].score | 0.32806259393692017 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[12].display_name | Internal medicine |
| concepts[13].id | https://openalex.org/C203014093 |
| concepts[13].level | 1 |
| concepts[13].score | 0.27602893114089966 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[13].display_name | Immunology |
| concepts[14].id | https://openalex.org/C86803240 |
| concepts[14].level | 0 |
| concepts[14].score | 0.20154327154159546 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[14].display_name | Biology |
| concepts[15].id | https://openalex.org/C142724271 |
| concepts[15].level | 1 |
| concepts[15].score | 0.15199881792068481 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[15].display_name | Pathology |
| concepts[16].id | https://openalex.org/C202751555 |
| concepts[16].level | 2 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[16].display_name | In vitro |
| concepts[17].id | https://openalex.org/C124952713 |
| concepts[17].level | 1 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q8242 |
| concepts[17].display_name | Literature |
| concepts[18].id | https://openalex.org/C142362112 |
| concepts[18].level | 0 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q735 |
| concepts[18].display_name | Art |
| concepts[19].id | https://openalex.org/C55493867 |
| concepts[19].level | 1 |
| concepts[19].score | 0.0 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[19].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/cisplatin |
| keywords[0].score | 0.817870557308197 |
| keywords[0].display_name | Cisplatin |
| keywords[1].id | https://openalex.org/keywords/mesothelioma |
| keywords[1].score | 0.7890313863754272 |
| keywords[1].display_name | Mesothelioma |
| keywords[2].id | https://openalex.org/keywords/immune-system |
| keywords[2].score | 0.5757443308830261 |
| keywords[2].display_name | Immune system |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.5644565224647522 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/tumor-microenvironment |
| keywords[4].score | 0.5321850776672363 |
| keywords[4].display_name | Tumor microenvironment |
| keywords[5].id | https://openalex.org/keywords/chemotherapy |
| keywords[5].score | 0.5094864964485168 |
| keywords[5].display_name | Chemotherapy |
| keywords[6].id | https://openalex.org/keywords/cancer-research |
| keywords[6].score | 0.4733445942401886 |
| keywords[6].display_name | Cancer research |
| keywords[7].id | https://openalex.org/keywords/immune-checkpoint |
| keywords[7].score | 0.47064799070358276 |
| keywords[7].display_name | Immune checkpoint |
| keywords[8].id | https://openalex.org/keywords/cytotoxicity |
| keywords[8].score | 0.46917206048965454 |
| keywords[8].display_name | Cytotoxicity |
| keywords[9].id | https://openalex.org/keywords/dual |
| keywords[9].score | 0.4238210618495941 |
| keywords[9].display_name | Dual (grammatical number) |
| keywords[10].id | https://openalex.org/keywords/oncology |
| keywords[10].score | 0.3917440176010132 |
| keywords[10].display_name | Oncology |
| keywords[11].id | https://openalex.org/keywords/immunotherapy |
| keywords[11].score | 0.32911813259124756 |
| keywords[11].display_name | Immunotherapy |
| keywords[12].id | https://openalex.org/keywords/internal-medicine |
| keywords[12].score | 0.32806259393692017 |
| keywords[12].display_name | Internal medicine |
| keywords[13].id | https://openalex.org/keywords/immunology |
| keywords[13].score | 0.27602893114089966 |
| keywords[13].display_name | Immunology |
| keywords[14].id | https://openalex.org/keywords/biology |
| keywords[14].score | 0.20154327154159546 |
| keywords[14].display_name | Biology |
| keywords[15].id | https://openalex.org/keywords/pathology |
| keywords[15].score | 0.15199881792068481 |
| keywords[15].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1158/2326-6066.28333082 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/2326-6066.28333082 |
| locations[1].id | pmh:oai:figshare.com:article/28333082 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Journal contribution |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Hyperthermic_Intrathoracic_Chemotherapy_Modulates_the_Immune_Microenvironment_of_Pleural_Mesothelioma_and_Improves_the_Impact_of_Dual_Immune_Checkpoint_Inhibition/28333082 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5076644180 |
| authorships[0].author.orcid | https://orcid.org/0009-0006-2142-2562 |
| authorships[0].author.display_name | Yameng Hao |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yameng Hao |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5031369273 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Aspasia Gkasti |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Aspasia Gkasti |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5090091220 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1479-0843 |
| authorships[2].author.display_name | Amy J. Managh |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Amy J. Managh |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5075922013 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-3864-5149 |
| authorships[3].author.display_name | Julien Dagher |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Julien Dagher |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5114787276 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Alexandros Sifis |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Alexandros Sifis |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5114787277 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Luca Tiron |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Luca Tiron |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5075761575 |
| authorships[6].author.orcid | https://orcid.org/0009-0003-1177-487X |
| authorships[6].author.display_name | Louis-Emmanuel Chriqui |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Louis-Emmanuel Chriqui |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5057576852 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-8848-2053 |
| authorships[7].author.display_name | Damien N. Marie |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Damien N. Marie |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5002803212 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-1314-536X |
| authorships[8].author.display_name | Olga De Souza Silva |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Olga De Souza Silva |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5110524564 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-6185-3571 |
| authorships[9].author.display_name | Michel Christodoulou |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Michel Christodoulou |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5063300526 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-0412-7143 |
| authorships[10].author.display_name | Solange Peters |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Solange Peters |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5009785954 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-6332-2598 |
| authorships[11].author.display_name | Johanna A. Joyce |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Johanna A. Joyce |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5113597577 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-0546-239X |
| authorships[12].author.display_name | Thorsten Krueger |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Thorsten Krueger |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5043759074 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-8705-4279 |
| authorships[13].author.display_name | Michel González |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Michel Gonzalez |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5035698554 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-4002-9046 |
| authorships[14].author.display_name | Etienne Abdelnour‐Berchtold |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Etienne Abdelnour-Berchtold |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5052684432 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-1375-3979 |
| authorships[15].author.display_name | Christine Sempoux |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Christine Sempoux |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5033353173 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-9285-3312 |
| authorships[16].author.display_name | Daniel Clerc |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Daniel Clerc |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5079670986 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-9786-5208 |
| authorships[17].author.display_name | Hugo Teixeira Farinha |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Hugo Teixeira-Farinha |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5069670123 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-4521-8279 |
| authorships[18].author.display_name | Martin Hübner |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Martin Hübner |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5008398236 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-0899-2230 |
| authorships[19].author.display_name | Etienne Meylan |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Etienne Meylan |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5044433603 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-3117-3249 |
| authorships[20].author.display_name | Paul J. Dyson |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Paul J. Dyson |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5090356141 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-1993-4503 |
| authorships[21].author.display_name | Sabrina Cavin |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Sabrina Cavin |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5076907343 |
| authorships[22].author.orcid | https://orcid.org/0000-0001-7918-0793 |
| authorships[22].author.display_name | Jean Yannis Perentes |
| authorships[22].author_position | last |
| authorships[22].raw_author_name | Jean Y. Perentes |
| authorships[22].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/2326-6066.28333082 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figure S1 from Hyperthermic Intrathoracic Chemotherapy Modulates the Immune Microenvironment of Pleural Mesothelioma and Improves the Impact of Dual Immune Checkpoint Inhibition |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11026 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9782000184059143 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Occupational and environmental lung diseases |
| related_works | https://openalex.org/W2091461259, https://openalex.org/W2406608798, https://openalex.org/W2080420195, https://openalex.org/W2406596433, https://openalex.org/W4200022043, https://openalex.org/W2112727616, https://openalex.org/W2884525857, https://openalex.org/W4322720888, https://openalex.org/W4296613612, https://openalex.org/W3193904228 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/2326-6066.28333082 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/2326-6066.28333082 |
| primary_location.id | doi:10.1158/2326-6066.28333082 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/2326-6066.28333082 |
| publication_date | 2025-02-03 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.of | 4, 7 |
| abstract_inverted_index.on | 10 |
| abstract_inverted_index.S1: | 2 |
| abstract_inverted_index.the | 5 |
| abstract_inverted_index.heat | 8 |
| abstract_inverted_index.Figure | 1 |
| abstract_inverted_index.impact | 6 |
| abstract_inverted_index.adjunct | 9 |
| abstract_inverted_index.cisplatin | 11 |
| abstract_inverted_index.Evaluation | 3 |
| abstract_inverted_index.<p>Supplementary | 0 |
| abstract_inverted_index.cytotoxicity.</p> | 12 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 23 |
| citation_normalized_percentile.value | 0.04713601 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |